Skip to main content
Premium Trial:

Request an Annual Quote

Gene-IT Secures $4M in Series A Financing

NEW YORK, Nov. 30 (GenomeWeb News) - Gene-IT has secured $4.1 million through a Series A round of venture-capital financing, the company said today.

 

Gene-IT said it plans to use the funds to expand sales and marketing programs aimed at discovery scientists and attorneys in major markets in North America and Europe. It also will expand its flagship GenomeQuest software's capabilities to address emerging applications of sequence search in areas such as RNAi and diagnostics next year, it said.

 

The financing was led by Cross Atlantic Partners and Milestone Venture Partners, based in New York, with reinvestment by Paris-based Société Générale Asset Management Alternative Investments, according to Gene-IT.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people 65 and older or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.